ExLibris header image
SFX Logo
Title: The role of patiromer: Comparing OPAL-HK data with untreated real-world patients in the United Kingdom—A retrospective, propensity-matched analysis
Source:

Plos One [1932-6203] Ali, Ibrahim yr:2020


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Sutherland, J. "Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden." PharmacoEconomics 38.7 (2020): 747-764. Link to SFX for this item
2. Kovesdy, Csaba P. "Real-world management of hyperkalemia with patiromer among United States Veterans." Postgraduate Medicine 132.2 (2020): 176-183. Link to SFX for this item
3. Desai, N. "A medication use evaluation of patiromer in a clinical practice setting at a veteran's affairs medical center." Journal of the American Society of Nephrology 31 (2020): 228-. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced